Can I get it?
Yes, if a doctor decides it is right for you. Liraglutide is authorised in the EU and can be prescribed after a medical review.
Liraglutide · GijónPrescription only
Online medical consultation for Liraglutide in Gijón.
An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid in any pharmacy in Spain. Consultation €25/month, refunded if the doctor decides it is not safe to prescribe.
- Daily pen with flexible titration
- One of the longest-standing GLP-1s in Europe
- An option when a weekly GLP-1 isn't the right fit
Start consultationStart consultation · €25/month
Full refund if a review is not approved · Medication, if prescribed, is dispensed and paid for separately at a pharmacy.
IN PLAIN TERMS
What Liraglutide is, and how to get treatment
Liraglutide is a medicine given as an injection under the skin once a day. Like semaglutide, it copies the natural gut hormone GLP-1, which tells the brain you have had enough to eat, so hunger and food cravings go down. For weight management in the EU it is sold as Saxenda and is used together with a reduced-calorie diet and more physical activity. It has been authorised in the EU for weight management since March 2015.
Liraglutide has been authorised for use in the EU since 23 March 2015, so a licensed doctor can prescribe it when it is clinically appropriate for you.
Learn more about peptides at Peptidepedia.
What can I take instead?
Our doctors review every Weight loss option and recommend what fits your history and goals.
See all Weight loss optionsWhat do the studies show?
Every trial behind Liraglutide is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.
Jump to the studiesLocal consultation facts
Can I get Liraglutide in Gijón?
Yes. People in Gijón, Spain, can request an online doctor consultation about Liraglutide with Hi-Doctor. A licensed EU doctor reviews the case and issues a prescription only when clinically appropriate. If approved, the electronic prescription arrives as a QR code that can be dispensed directly in Spain.
Availability
Liraglutide is available to residents of Spain through the online consultation. A prescription follows only if the doctor approves it.
- Country
- Spain
- Language of service
- Spanish and English
- Prescription turnaround
- In less than 4 hours on average, only if the doctor approves
- Honoured locally
- QR electronic prescription, dispensed directly in Spain
How the EU prescription works where you are: In Spain, an approved prescription arrives electronically with a QR code for direct dispensing.
VERIFIED EVIDENCE
Liraglutide: evidence and regulatory guide.
WHAT IT IS
How it works
It copies the gut hormone GLP-1, which increases the feeling of fullness and reduces hunger and food cravings.
- GLP-1
DEVELOPMENT STAGE
EU-authorised medicine
Trial register1 registered trials
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| SCALE Obesity and Prediabetes (NN8022-1839)NCT01272219 | Adults with a BMI of 30 kg/m² or more, or 27 kg/m² or more with treated high blood pressure or abnormal blood fats, without type 2 diabetes; all received lifestyle counselling | 3,731 | Read out | 2015-07-02 |
What the studies reported
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
Peer-reviewed
Pi-Sunyer X, Astrup A, Fujioka K, et al; SCALE Obesity and Prediabetes NN8022-1839 Study Group. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. doi:10.1056/NEJMoa1411892 (PMID 26132939)| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| 3.0 mg once daily | −8.0% | 56 |
| Placebo | −2.6% | 56 |
Everyone in the trial also received lifestyle counselling, people with type 2 diabetes were excluded, and the primary result covers 56 weeks only.
NAMED SAFETY SIGNALS
What has been reported with Liraglutide.
Nausea
Reported by 40.2% of people on liraglutide 3.0 mg versus 14.7% on placebo in the SCALE Obesity and Prediabetes trial.
Diarrhoea
Reported by 20.9% on liraglutide 3.0 mg versus 9.3% on placebo in the same trial.
Constipation
Reported by 20.0% on liraglutide 3.0 mg versus 8.7% on placebo in the same trial.
Vomiting
Reported by 16.3% on liraglutide 3.0 mg versus 4.1% on placebo in the same trial.
Gallstone problems
Acute gallstone events were reported by 2.3% on liraglutide 3.0 mg versus 0.9% on placebo across the EMA weight-management trial pool, mainly gallstones (1.5% versus 0.5%).
Acute pancreatitis
Independently confirmed in 7 people (0.2%) on liraglutide 3.0 mg versus 1 person (under 0.1%) on placebo across the EMA weight-management trial pool.
Serious side effects overall
Serious adverse events were reported in 6.2% of the liraglutide group versus 5.0% of the placebo group in the SCALE Obesity and Prediabetes trial.
FormPre-filled injection pen
FrequencyOnce a day
ResultsGradual, week by week
StatusPrescription only
About
What is Liraglutide?
Active ingredient: Liraglutide · Dosages: 0.6 – 3 mg / day
Liraglutide is a GLP-1 receptor agonist given as a daily subcutaneous injection. It was one of the first in its class approved in Europe for weight management in adults with obesity, or overweight with comorbidities.
Compared with weekly GLP-1s, its daily dosing can be useful when flexibility of adjustment matters or when a semaglutide hasn't been tolerated. The doctor weighs this up in your consultation — two GLP-1 agonists are never combined.
How it works in the body
Like other GLP-1 analogues, liraglutide mimics a natural gut hormone: it eases hunger signals and produces earlier fullness, so you tend to eat less. Being shorter-acting, its dose is adjusted day by day.
How it helps
Three ways it supports weight loss.
Eases appetite
Earlier fullness and calmer hunger signals through the day.
Flexible dosing
Daily titration lets the doctor fine-tune the dose to your tolerance.
Long EU history
Among the first weight-management GLP-1s approved in Europe.
What to expect
A gradual, week-by-week build-up.
Treatment starts at a low daily dose and steps up through the intermediate doses as tolerated. Your doctor sets the pace and adjusts if side effects appear.
- Week 1 · 0.6 mg daily starting dose
- Following weeks · Step up through 1.2, 1.8 and 2.4 mg as tolerated
- Maintenance · 3 mg daily when appropriate
- Ongoing · Follow-up through your account chat
Typical escalation
- Starting dose0.6 mg / day
- Step-ups1.2 → 1.8 → 2.4 mg / day
- Maintenance3 mg / day
Your schedule is personal
These are typical steps only. Your doctor adjusts the plan to how you respond and tolerate it — and you can message them at any point.
Safety first
Safety, in full.
Liraglutide is an effective medicine — and like any medicine it carries risks. Your doctor screens for all of this before prescribing. Here's the honest picture, not just reassurance.
Adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition such as type 2 diabetes, high blood pressure or dyslipidaemia.
- Once-daily self-injection into the thigh, abdomen or upper arm, at any time of day but ideally at the same time each day.
- The dose is built up week by week to the maintenance dose, to limit digestive side effects.
- Works alongside diet and physical activity — it does not replace lifestyle change.
Who should not take it
- Allergy to liraglutide or any ingredient of the injection.
- Pregnancy, planning a pregnancy, or breastfeeding.
- Not to be combined with other GLP-1 receptor agonists.
- Not recommended in severe kidney or liver impairment, or in severe heart failure.
- Tell your doctor about any history of pancreatitis or gallstones.
When to seek urgent care
For severe, sudden or unexpected symptoms, call your local emergency number or go to the nearest emergency department. Then let your doctor know through your account chat.
PRICING
You only pay if treatment is approved.
€25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth. €35 one-off is available for sexual health.
Weight loss
ONGOING PLAN
€25/month
Billed €25 every 28 days · cancel anytime
28-day treatment cycle
For ongoing treatment and doctor-reviewed renewals.
Renewals reviewed by your doctor
Start consultation
Full refund if a review is not approved
WHAT'S INCLUDED
- First consultation included
- Renewals reviewed by your doctor
- Ongoing care with your doctor
- Cancel anytime
Full refund if a review is not approved
If a review is not approved, we refund that period's €25 fee and cancel the plan.
Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.
HOW THE DOCTOR DECIDES
A licensed doctor reviews your case, not an algorithm
An EU-licensed doctor reads your questionnaire and answers in less than 2 hours on average.
If the doctor decides it is not safe to prescribe, the consultation fee is refunded in full.
Follow-up happens in the private chat inside your account, under GDPR. No WhatsApp, no SMS.
OTHER WEIGHT LOSS TREATMENTS
Explore related treatments.
Find out if it's right for you
See if Liraglutide is appropriate for you.
Answer a few questions and a licensed EU doctor reviews your case in less than 2 hours on average. Refunded in full if it's not right for you.